Symbols / LFWD Stock $6.49 +1.84% Lifeward Ltd.

Healthcare • Medical Devices • Israel • NCM
LFWD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. William Mark Grant
Exch · Country NCM · Israel
Market Cap 18.03M
Enterprise Value 7.85M
Income -25.87M
Sales 20.92M
FCF (ttm) -8.68M
Book/sh 5.52
Cash/sh 7.09
Employees 81
Insider 10d —
IPO Sep 12, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -3.65
PEG —
P/S 0.86
P/B 1.18
P/C —
EV/EBITDA -0.46
EV/Sales 0.38
Quick Ratio 1.61
Current Ratio 2.40
Debt/Eq 140.10
LT Debt/Eq —
EPS (ttm) -18.34
EPS next Y -1.78
EPS Growth —
Revenue Growth -22.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-13
Earnings (prior) 2026-03-18
ROA -34.99%
ROE -209.10%
ROIC —
Gross Margin 36.55%
Oper. Margin -121.67%
Profit Margin -123.66%
Shs Outstand 2.78M
Shs Float 876.59K
Insider Own 33.73%
Instit Own 0.59%
Short Float 5.06%
Short Ratio 17.79
Short Interest 139.69K
52W High 15.36
vs 52W High -57.75%
52W Low 4.14
vs 52W Low 56.76%
Beta 0.33
Impl. Vol. 62.31%
Rel Volume 0.20
Avg Volume 14.06K
Volume 2.79K
Target (mean) $20.00
Tgt Median $20.00
Tgt Low $10.00
Tgt High $30.00
# Analysts 2
Recom Strong_buy
Prev Close $6.37
Price $6.49
Change 1.84%
About

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$20.00
Mean price target
2. Current target
$6.49
Latest analyst target
3. DCF / Fair value
$-56.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.49
Low
$10.00
High
$30.00
Mean
$20.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-19 main HC Wainwright & Co. Buy → Buy $10
2025-11-18 main HC Wainwright & Co. Buy → Buy $5
2025-03-11 main Lake Street Buy → Buy $4
2025-03-11 reit HC Wainwright & Co. Buy → Buy $13
2025-02-20 main Lake Street Buy → Buy $5
2025-02-20 reit HC Wainwright & Co. Buy → Buy $13
2025-02-10 init Laidlaw & Co. — → Buy $10
2024-11-13 reit HC Wainwright & Co. Buy → Buy $13
2024-08-16 main HC Wainwright & Co. Buy → Buy $13
2024-05-16 main HC Wainwright & Co. Buy → Buy $13
2024-04-15 reit HC Wainwright & Co. Buy → Buy $9
2024-02-28 reit HC Wainwright & Co. Buy → Buy $3
2023-11-15 reit HC Wainwright & Co. Buy → Buy $3
2023-08-14 reit HC Wainwright & Co. Buy → Buy $3
2023-08-10 reit HC Wainwright & Co. Buy → Buy $3
2023-07-03 reit HC Wainwright & Co. Buy → Buy $3
2023-05-12 reit HC Wainwright & Co. Buy → Buy $3
2023-02-24 reit HC Wainwright & Co. — → Buy $3
2022-11-15 main HC Wainwright & Co. — → Buy $3
2022-08-10 main HC Wainwright & Co. — → Buy $3
News
RSS: Latest LFWD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-25 KIDRON NADAV Director — 7,657 $0.00 $0
2026-03-25 KIDRON MIRIAM Director — 7,657 $0.00 $0
2026-03-25 REZNICK YEHUDA Director — 7,657 $0.00 $0
2026-03-25 ROZENBAUM MOSHE H Director — 11,485 $0.00 $0
2026-03-25 SIGSBEE WILLIAM MARK Director — 11,485 $0.00 $0
2025-12-11 LYNCH JEANNINE Officer — 50,000 — —
2025-09-02 LYNCH JEANNINE Officer — 1,591 $0.64 $1,018
2025-08-01 PODUSKA JOHN WILLIAM SR Director — 35,920 — —
2025-08-01 TURK JOSEPH E JR Director — 71,839 — —
2025-08-01 MARSHALL ROBERT J. JR. Director — 35,920 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
22.03
-14.14%
25.66
+85.24%
13.85
+151.39%
5.51
Operating Revenue
22.03
-14.14%
25.66
+85.24%
13.85
+151.39%
5.51
Cost Of Revenue
13.61
-22.02%
17.45
+85.59%
9.40
+160.70%
3.61
Reconciled Cost Of Revenue
13.61
-22.02%
17.45
+85.59%
9.40
+160.70%
3.61
Gross Profit
8.43
+2.58%
8.22
+84.50%
4.45
+133.75%
1.91
Operating Expense
25.32
-8.82%
27.77
-1.05%
28.07
+33.60%
21.01
Research And Development
3.25
-29.75%
4.62
+11.50%
4.15
+2.90%
4.03
Selling General And Administration
22.07
-4.64%
23.14
-3.23%
23.92
+40.89%
16.98
Selling And Marketing Expense
13.88
-22.70%
17.95
+28.93%
13.92
+41.45%
9.84
General And Administrative Expense
8.20
+57.75%
5.20
-48.02%
9.99
+40.10%
7.13
Other Gand A
8.20
+57.75%
5.20
-48.02%
9.99
+40.10%
7.13
Total Expenses
38.92
-13.91%
45.22
+20.69%
37.47
+52.22%
24.61
Operating Income
-16.89
+13.61%
-19.55
+17.19%
-23.61
-23.61%
-19.10
Total Operating Income As Reported
-19.67
+32.96%
-29.35
-24.29%
-23.61
-23.61%
-19.10
EBITDA
-16.56
-5.38%
-15.71
+27.81%
-21.77
-15.16%
-18.90
Normalized EBITDA
-13.92
-137.86%
-5.85
+73.28%
-21.90
-15.73%
-18.92
Reconciled Depreciation
0.33
-91.33%
3.84
+107.96%
1.85
+814.36%
0.20
EBIT
-16.89
+13.61%
-19.55
+17.19%
-23.61
-23.61%
-19.10
Total Unusual Items
-2.64
+73.22%
-9.86
-7514.29%
0.13
+504.55%
0.02
Total Unusual Items Excluding Goodwill
-2.64
+73.22%
-9.86
-7514.29%
0.13
+504.55%
0.02
Special Income Charges
-2.78
+71.58%
-9.79
0.00
0.00
Impairment Of Capital Assets
2.78
-71.58%
9.79
0.00
0.00
Write Off
—
9.79
0.00
0.00
Net Income
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Pretax Income
-19.97
+30.90%
-28.90
-30.50%
-22.14
-15.93%
-19.10
Net Non Operating Interest Income Expense
-0.44
-184.85%
0.52
-61.39%
1.33
+6163.64%
-0.02
Interest Expense Non Operating
—
—
—
0.00
Net Interest Income
-0.44
-184.85%
0.52
-61.39%
1.33
+6163.64%
-0.02
Interest Expense
—
—
—
0.00
Interest Income Non Operating
—
0.64
-52.51%
1.35
0.00
Interest Income
—
0.64
-52.51%
1.35
0.00
Other Income Expense
-2.64
+73.22%
-9.86
-7514.29%
0.13
+504.55%
0.02
Gain On Sale Of Security
0.14
+311.94%
-0.07
-150.38%
0.13
+504.55%
0.02
Tax Provision
-0.06
-227.91%
0.04
+458.33%
-0.01
-102.57%
0.47
Tax Rate For Calcs
0.00
-98.57%
0.00
+38645.39%
0.00
-99.74%
0.00
Tax Effect Of Unusual Items
-0.01
+99.62%
-2.07
-2873413.74%
0.00
-98.44%
0.00
Net Income Including Noncontrolling Interests
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Net Income From Continuing Operation Net Minority Interest
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Net Income From Continuing And Discontinued Operation
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Net Income Continuous Operations
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Normalized Income
-17.28
+18.30%
-21.15
+5.00%
-22.27
-13.68%
-19.59
Net Income Common Stockholders
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Diluted EPS
-17.16
+57.06%
-39.96
-28.36%
-31.13
-18.14%
-26.35
Basic EPS
-17.16
+57.06%
-39.96
-28.57%
-31.08
-19.35%
-26.04
Basic Average Shares
1.16
+60.23%
0.72
+1.88%
0.71
-4.26%
0.74
Diluted Average Shares
1.16
+60.23%
0.72
+1.88%
0.71
-4.26%
0.74
Diluted NI Availto Com Stockholders
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Total Other Finance Cost
0.44
+184.85%
-0.52
+61.39%
-1.33
-6163.64%
0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
22.90
-24.89%
30.49
-51.75%
63.19
-14.88%
74.24
Current Assets
15.81
-25.77%
21.29
-45.71%
39.22
-45.91%
72.51
Cash Cash Equivalents And Short Term Investments
2.17
-67.85%
6.75
-75.98%
28.08
-58.64%
67.90
Cash And Cash Equivalents
2.17
-67.85%
6.75
-75.98%
28.08
-58.64%
67.90
Receivables
6.14
+2.23%
6.00
+92.44%
3.12
+201.16%
1.04
Accounts Receivable
6.14
+2.23%
6.00
+92.44%
3.12
+201.16%
1.04
Gross Accounts Receivable
6.33
+2.69%
6.16
+78.77%
3.45
+224.67%
1.06
Allowance For Doubtful Accounts Receivable
-0.19
-20.00%
-0.16
+51.22%
-0.33
-1161.54%
-0.03
Inventory
5.73
-14.74%
6.72
+18.93%
5.65
+93.00%
2.93
Raw Materials
2.00
-36.21%
3.14
+25.92%
2.50
+391.34%
0.51
Work In Process
0.04
0.00
—
—
Finished Goods
3.69
+3.04%
3.58
+13.40%
3.16
+30.40%
2.42
Prepaid Assets
0.92
-12.33%
1.05
-23.43%
1.37
+228.37%
0.42
Restricted Cash
0.24
+21.83%
0.20
0.00
—
Other Current Assets
0.61
+5.71%
0.58
-42.20%
1.00
+329.18%
0.23
Total Non Current Assets
7.09
-22.84%
9.19
-61.65%
23.97
+1288.76%
1.73
Net PPE
2.13
+50.46%
1.42
-54.69%
3.12
+202.62%
1.03
Gross PPE
9.44
+11.73%
8.45
-10.72%
9.46
+103.22%
4.66
Accumulated Depreciation
-7.31
-3.94%
-7.03
-10.93%
-6.34
-74.92%
-3.62
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
2.80
+0.61%
2.78
+0.00%
2.78
+66.21%
1.67
Other Properties
5.99
+19.43%
5.01
-16.84%
6.03
+127.26%
2.65
Leases
0.66
+0.00%
0.66
+0.00%
0.66
+97.60%
0.33
Goodwill And Other Intangible Assets
4.75
-36.92%
7.54
-62.43%
20.06
0.00
Goodwill
4.75
-36.92%
7.54
+0.00%
7.54
0.00
Other Intangible Assets
—
—
12.53
—
Other Non Current Assets
0.21
-12.92%
0.24
-69.39%
0.78
+12.97%
0.69
Total Liabilities Net Minority Interest
14.49
+24.52%
11.64
-30.24%
16.68
+174.78%
6.07
Current Liabilities
12.04
+17.74%
10.22
-13.31%
11.79
+146.65%
4.78
Payables And Accrued Expenses
7.03
+10.67%
6.35
-10.54%
7.10
+119.77%
3.23
Payables
5.59
+11.31%
5.02
-0.93%
5.07
+159.95%
1.95
Accounts Payable
5.59
+11.31%
5.02
-0.93%
5.07
+159.95%
1.95
Current Accrued Expenses
1.44
+8.26%
1.33
-34.51%
2.03
+58.66%
1.28
Pensionand Other Post Retirement Benefit Plans Current
—
—
2.03
+58.66%
1.28
Current Debt And Capital Lease Obligation
3.23
+276.22%
0.86
-33.80%
1.30
+129.79%
0.56
Current Debt
2.80
—
—
—
Other Current Borrowings
2.80
—
—
—
Current Capital Lease Obligation
0.42
-50.47%
0.86
-33.80%
1.30
+129.79%
0.56
Current Deferred Liabilities
0.92
-26.28%
1.25
-17.02%
1.50
+399.67%
0.30
Current Deferred Revenue
0.92
-26.28%
1.25
-17.02%
1.50
+399.67%
0.30
Other Current Liabilities
0.86
-51.33%
1.76
-6.71%
1.89
+176.20%
0.69
Total Non Current Liabilities Net Minority Interest
2.45
+73.60%
1.41
-71.09%
4.89
+279.13%
1.29
Long Term Debt And Capital Lease Obligation
1.16
+5168.18%
0.02
-96.38%
0.61
+82.28%
0.33
Long Term Capital Lease Obligation
1.16
+5168.18%
0.02
-96.38%
0.61
+82.28%
0.33
Non Current Deferred Liabilities
1.23
-6.87%
1.32
-12.08%
1.51
+69.21%
0.89
Non Current Deferred Revenue
1.23
-6.87%
1.32
-12.08%
1.51
+69.21%
0.89
Other Non Current Liabilities
0.06
-8.96%
0.07
-97.58%
2.77
+4103.03%
0.07
Stockholders Equity
8.41
-55.39%
18.85
-59.47%
46.51
-31.77%
68.17
Common Stock Equity
8.41
-55.39%
18.85
-59.47%
46.51
-31.77%
68.17
Capital Stock
9.42
+105.19%
4.59
+2.30%
4.49
-0.04%
4.49
Common Stock
9.42
+105.19%
4.59
+2.30%
4.49
-0.04%
4.49
Share Issued
1.57
+101.09%
0.78
+2.41%
0.76
+1.76%
0.75
Ordinary Shares Number
1.52
+107.68%
0.73
+2.57%
0.72
+0.03%
0.72
Treasury Shares Number
0.05
0.00%
0.05
+0.00%
0.05
+37.14%
0.03
Additional Paid In Capital
286.93
+1.65%
282.29
+0.42%
281.11
+0.45%
279.86
Retained Earnings
-284.74
-7.52%
-264.82
-12.27%
-235.88
-10.35%
-213.75
Treasury Stock
3.20
+0.00%
3.20
+0.00%
3.20
+31.76%
2.43
Total Equity Gross Minority Interest
8.41
-55.39%
18.85
-59.47%
46.51
-31.77%
68.17
Total Capitalization
8.41
-55.39%
18.85
-59.47%
46.51
-31.77%
68.17
Working Capital
3.77
-65.96%
11.07
-59.64%
27.43
-59.50%
67.73
Invested Capital
11.21
-40.52%
18.85
-59.47%
46.51
-31.77%
68.17
Total Debt
4.39
+398.52%
0.88
-53.76%
1.90
+112.15%
0.90
Net Debt
0.63
—
—
—
Capital Lease Obligations
1.58
+80.00%
0.88
-53.76%
1.90
+112.15%
0.90
Net Tangible Assets
3.65
-67.70%
11.31
-57.23%
26.45
-61.20%
68.17
Tangible Book Value
3.65
-67.70%
11.31
-57.23%
26.45
-61.20%
68.17
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-16.83
+22.53%
-21.72
-5.09%
-20.67
-15.52%
-17.89
Cash Flow From Continuing Operating Activities
-16.83
+22.53%
-21.72
-5.09%
-20.67
-15.52%
-17.89
Net Income From Continuing Operations
-19.91
+31.19%
-28.94
-30.76%
-22.13
-13.10%
-19.57
Depreciation Amortization Depletion
0.33
-91.33%
3.84
+107.96%
1.85
+814.36%
0.20
Depreciation
0.33
-32.59%
0.49
+106.69%
0.24
+18.32%
0.20
Amortization Cash Flow
0.00
-100.00%
3.35
+108.15%
1.61
0.00
Depreciation And Amortization
0.33
-91.33%
3.84
+107.96%
1.85
+814.36%
0.20
Amortization Of Intangibles
0.00
-100.00%
3.35
+108.15%
1.61
0.00
Other Non Cash Items
-0.17
+93.82%
-2.68
-723.31%
-0.33
—
Stock Based Compensation
0.74
-42.00%
1.28
-3.54%
1.33
+33.74%
0.99
Asset Impairment Charge
2.78
-71.58%
9.79
0.00
0.00
Deferred Tax
—
0.00
0.00
-100.00%
0.32
Deferred Income Tax
—
0.00
0.00
-100.00%
0.32
Operating Gains Losses
-0.31
-802.94%
-0.03
+24.44%
-0.04
-156.96%
0.08
Gain Loss On Investment Securities
-0.20
—
—
—
Net Foreign Currency Exchange Gain Loss
-0.11
-223.53%
-0.03
+24.44%
-0.04
-156.96%
0.08
Change In Working Capital
-0.30
+94.01%
-4.97
-271.75%
-1.34
-1620.45%
0.09
Change In Receivables
-0.13
+95.35%
-2.88
-827.33%
-0.31
+23.77%
-0.41
Changes In Account Receivables
-0.13
+95.35%
-2.88
-827.33%
-0.31
+23.77%
-0.41
Change In Inventory
0.90
+197.39%
-0.92
-232.13%
-0.28
-136.75%
-0.12
Change In Prepaid Assets
0.19
+2.13%
0.19
+128.66%
-0.66
-797.87%
0.09
Change In Payables And Accrued Expense
-0.24
+68.36%
-0.75
-173.22%
1.02
+44.90%
0.71
Change In Accrued Expense
0.11
+115.67%
-0.70
-4914.29%
-0.01
-110.00%
0.14
Change In Payable
-0.35
-638.30%
-0.05
-104.53%
1.04
+83.22%
0.57
Change In Account Payable
-0.35
-638.30%
-0.05
-104.53%
1.04
+83.22%
0.57
Change In Other Working Capital
-0.42
+4.34%
-0.44
-62.83%
-0.27
-691.18%
-0.03
Change In Other Current Assets
0.44
-63.26%
1.20
+856.00%
0.12
—
Change In Other Current Liabilities
-1.03
+24.23%
-1.37
-40.39%
-0.97
-535.95%
-0.15
Investing Cash Flow
-0.02
0.00
+100.00%
-18.15
-72496.00%
-0.03
Cash Flow From Continuing Investing Activities
-0.02
0.00
+100.00%
-18.15
-72496.00%
-0.03
Net PPE Purchase And Sale
-0.02
0.00
+100.00%
-0.08
-224.00%
-0.03
Purchase Of PPE
-0.02
0.00
+100.00%
-0.08
-224.00%
-0.03
Capital Expenditure
-0.02
—
-0.08
-224.00%
-0.03
Net Business Purchase And Sale
0.00
0.00
+100.00%
-18.07
0.00
Purchase Of Business
0.00
0.00
+100.00%
-18.07
0.00
Financing Cash Flow
12.20
0.00
+100.00%
-0.99
+60.32%
-2.50
Cash Flow From Continuing Financing Activities
12.20
0.00
+100.00%
-0.99
+60.32%
-2.50
Net Issuance Payments Of Debt
1.44
0.00
0.00
0.00
Issuance Of Debt
1.44
0.00
0.00
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Short Term Debt Issuance
1.44
0.00
0.00
—
Net Short Term Debt Issuance
1.44
0.00
0.00
—
Net Common Stock Issuance
9.20
0.00
+100.00%
-0.99
+60.32%
-2.50
Common Stock Payments
0.00
0.00
+100.00%
-0.99
+60.32%
-2.50
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-0.99
+60.32%
-2.50
Proceeds From Stock Option Exercised
—
—
0.00
0.00
Net Other Financing Charges
1.56
—
—
—
Changes In Cash
-4.64
+78.64%
-21.72
+45.44%
-39.81
-94.98%
-20.42
Effect Of Exchange Rate Changes
0.11
+223.53%
0.03
-24.44%
0.04
+156.96%
-0.08
Beginning Cash Position
7.11
-75.31%
28.79
-58.00%
68.56
-23.02%
89.05
End Cash Position
2.58
-63.72%
7.11
-75.31%
28.79
-58.00%
68.56
Free Cash Flow
-16.84
+22.45%
-21.72
-4.68%
-20.75
-15.81%
-17.92
Interest Paid Supplemental Data
—
—
1.34
0.00
Income Tax Paid Supplemental Data
—
—
0.13
+11.50%
0.11
Common Stock Issuance
9.20
0.00
0.00
0.00
Issuance Of Capital Stock
9.20
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category